Moneycontrol

Moneycontrol PRO

you are here: HomeNewsBusinessEarningsSun Pharma Q2 show healthy but margins unsustainable: Nangra

SHOW NAMES

Trending Topics

business

Sun Pharma Q2 show healthy but margins unsustainable: Nangra

Healthcare major Sun Pharmaceutical Industries' Profit more than doubled to Rs 2,235.1 crore in the quarter ended September 2016 compared with Rs 1,028.8 crore in year-ago period, driven by overall healthy business performance.

first published: Nov 10, 2016 04:42 pm

LATEST VIDEOS

A collection of the most-viewed Moneycontrol videos.

Watch and Follow our leading shows

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347